China Nuvo Solar Target Acquisition SurgLine Reports on Marketing Progress

WEST PALM BEACH, Fla., Aug. 24, 2011 /PRNewswire/ -- China Nuvo Solar Energy, Inc. (OTCQB: CNUV) today announced that SurgLine's various sales channels are all reporting success that is exceeding expectations for the distribution of the Company's product lines. The Company's plan of action to sell through stocking distributors as well as channel distributors and potentially with medical co-ops and other third party outsourcing solutions is being received better than originally forecasted throughout the industry. SurgLine's product lines include trauma, orthopedic, spine and ENT medical and surgical products selling into hospitals and surgery centers.

Mr. Tom Toland, CEO of SurgLine was quoted as saying "As we speak to CFO's and CEO's of hospitals and surgery centers across the country, one common theme seems to emerge, they must cut costs without sacrificing the quality and healthcare at their facilities. SurgLine is able to meet both of these expectations by providing significant cost savings while maintaining their existing product quality."

Toland continued, SurgLine's corporate business proposition is simple, "More Value for Your Healthcare Dollar." Our team has the ability to source the same or similar surgical and medical products from the original manufacturer sources and bring them to the end user with significant savings. As we begin to source more surgical and medical products for our potential clients, we anticipate deeper penetration as a result of savings we can provide for the client base.  In some instances, SurgLine is negotiating for the exclusive distribution rights to market these products in the United States, which will provide SurgLine with an even greater value proposition to the end users in these important markets."

Richard Dutch, COO of SurgLine stated "We believe all of our sales partners will have continued success by transitioning more of their customers and taking advantage of our value-based pricing that does not compromise quality to the end user. The downward reimbursement pressures from insurance payers including the Federal Government and State Governments continues to erode operating margins for the hospital and surgical center operators. We believe we will continue to see substantial demand for our high quality, low cost products to be of significant value as a result of the quantifiable savings we can provide. One would expect that our orders will climb as we continue to introduce our value line of surgical products known as SURG to the marketplace."